AMIRO Spectra 10-in-1 LED Light Therapy Mask (L3)
Shenzhen Accompany Technology Co., Ltd. · Decision date Oct 19, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-19 for the AMIRO Spectra 10-in-1 LED Light Therapy Mask (L3), submitted by Shenzhen Accompany Technology Co., Ltd. of Shenzhen, China, under 510(k) number K262932. The application was received 08/21/2026 and reviewed under regulation 878.4810, classification product code OHS, with OLP listed as a subsequent product code; the review panel and regulation medical specialty are General & Plastic Surgery.
SESE for a 510(k) means the device was cleared as substantially equivalent to a predicate, not approved through the PMA pathway. The record describes a traditional 510(k) that was not reviewed by a third party, is not a combination product, and has no authorized predetermined change control plan. The page does not state which predicate device was used, what testing supported equivalence, or any indications, dosing or treatment parameters; those details would sit in the underlying 510(k) documents rather than this summary listing.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Oct 19, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262932
- Regulatory pathway
- 510(k) premarket notification
- Product code
- OHS
- Decision code
- SESE
- Decision date
- Oct 19, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Light Based Over The Counter Wrinkle Reduction.
- Product code
- OHS
- FDA device class
- 2
FDA decision timeline
K262932 received
Application receipt date recorded by FDA.
K262932 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code OHS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Guangdong Newdermo Biotech Co., Ltd. | 510(k) clearance | Nov 4, 2026 | FDA | |
| Shenzhen Bway Tech Co., Ltd. | 510(k) clearance | Oct 26, 2026 | FDA | |
| Shenzhen Xinlong Precision Plastic Mold Products Co., Ltd. | 510(k) clearance | Oct 23, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Shenzhen Accompany Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shenzhen
Sources and methodology
- Original FDA record: K262932
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

